Cingulate Stock In The News

CING Stock  USD 4.14  0.04  0.96%   
Our overall analysis of Cingulate's news coverage and content from conventional and social sources shows investors' bearish mood towards Cingulate. The specific impact of Cingulate news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Cingulate's overall financial health and prospects. It also depends on the type and quality of a news publisher.
  
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Cingulate headlines in addition to utilizing other, more conventional financial analysis modules. Check out Cingulate Backtesting and Cingulate Hype Analysis.
For more detail on how to invest in Cingulate Stock please use our How to Invest in Cingulate guide.

Cingulate Today Top News and Investor Outlook

Yahoo News
Apple, Microsoft and AIG rise premarket; Marathon Digital falls
https://finance.yahoo.com/news/apple-microsoft-aig-rise-premarket-075425933.html
 Neutral
Macroaxis News: globenewswire.com
Cingulate Inc. Reports Third Quarter 2023 Financial Results and Provides Clinical and Business Update
https://www.globenewswire.com/news-release/2023/11/13/2779484/0/en/Cingulate-Inc-Reports-Third-Quarter-2023-Financial-Results-and-Provides-Clinical-and-Business-Update.html
 Neutral
Macroaxis News: globenewswire.com
Presenting on the Emerging Growth Conference 64 Day 1 on November 1 Register Now
https://www.globenewswire.com/news-release/2023/10/31/2769992/0/en/Presenting-on-the-Emerging-Growth-Conference-64-Day-1-on-November-1-Register-Now.html
 Bullish
Macroaxis News: globenewswire.com
Cingulate to Host CNS Key Opinion Leader Panel in New York City
https://www.globenewswire.com/news-release/2023/10/17/2761854/0/en/Cingulate-to-Host-CNS-Key-Opinion-Leader-Panel-in-New-York-City.html
 Neutral
Macroaxis News: globenewswire.com
Cingulate Inc. to Present at the LD Micro Main Event XVI
https://www.globenewswire.com/news-release/2023/09/21/2747595/0/en/Cingulate-Inc-to-Present-at-the-LD-Micro-Main-Event-XVI.html
 Bullish
Macroaxis News: globenewswire.com
Cingulate Announces Closing of $4.0 Million Public Offering
https://www.globenewswire.com/news-release/2023/09/13/2742881/0/en/Cingulate-Announces-Closing-of-4-0-Million-Public-Offering.html
 Bullish
Macroaxis News: globenewswire.com
Cingulate Announces Pricing of $4.0 Million Public Offering
https://www.globenewswire.com/news-release/2023/09/11/2740897/0/en/Cingulate-Announces-Pricing-of-4-0-Million-Public-Offering.html
 Bullish
Macroaxis News: globenewswire.com
Cingulate Announces Detailed Trial Results from Phase 3 Adult Efficacy and Safety Trial of CTx-1301 (dexmethylphenidate) for ADHD
https://www.globenewswire.com/news-release/2023/09/11/2740589/0/en/Cingulate-Announces-Detailed-Trial-Results-from-Phase-3-Adult-Efficacy-and-Safety-Trial-of-CTx-1301-dexmethylphenidate-for-ADHD.html
 Bullish
Macroaxis News: globenewswire.com
Werth Family Investment Associates Converts $5.8 Million of Debt into Cingulate Equity at a Premium
https://www.globenewswire.com/news-release/2023/09/08/2740335/0/en/Werth-Family-Investment-Associates-Converts-5-8-Million-of-Debt-into-Cingulate-Equity-at-a-Premium.html
 Bullish
Macroaxis News: globenewswire.com
Cingulate Announces Presentation of Full...
https://www.globenewswire.com/news-release/2023/09/05/2737266/0/en/Cingulate-Announces-Presentation-of-Full-Trial-Results-from-Phase-3-Adult-Efficacy-and-Safety-Trial-of-CTx-1301-dexmethylphenidate-for-ADHD-at-Psych-Congress-2023.html
 Bullish

Cingulate Past News Timeline

Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Cingulate and other traded companies coverage with news coverage. We help investors stay connected with Cingulate headlines for the 26th of February to make an informed investment decision based on correlating the impacts of news items on Cingulate Stock performance. Please note that trading solely based on the Cingulate hype is not for everyone as timely availability and quick action are needed to avoid losses.
Cingulate's linear event process diagram shows some of the filtered current and past headlines as well as many other corporate-specific events such as SEC filings, dividends, and regulatory reporting available to the public. This module can help Cingulate investors visualize upcoming and past events in order to time the market based on Cingulate noise-free hype analysis.
Cingulate stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Cingulate earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Cingulate that are available to investors today. That information is available publicly through Cingulate media outlets and privately through word of mouth or via Cingulate internal channels. However, regardless of the origin, that massive amount of Cingulate data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Cingulate news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Cingulate relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Cingulate's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Cingulate alpha.

Cingulate Largest EPS Surprises

Earnings surprises can significantly impact Cingulate's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2023-03-10
2022-12-31-0.37-0.41-0.0410 
2023-11-13
2023-09-30-0.37-0.30.0718 
2022-03-10
2021-12-31-0.39-0.320.0717 
2022-05-12
2022-03-31-0.23-0.44-0.2191 
2023-08-14
2023-06-30-0.35-0.57-0.2262 
2022-08-11
2022-06-30-0.58-0.360.2237 
View All Earnings Estimates

Cingulate Stock Latest Headlines

Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Cingulate Stock. The global stock market is bearish. About 62% of major world exchanges and indexes are down. See today's market update for more information.
Macroaxis News
18th of February 2025
Acquisition by Silva Raul R. of 17630 shares of Cingulate at 4.32 subject to Rule 16b-3
at MacroaxisInsider 
benzinga news
30th of January 2025
Meta Platforms To Rally Over 29 Here Are 10 Top Analyst Forecasts For Thursday
at benzinga.com 
Macroaxis News
22nd of January 2025
Acquisition by Silva Raul R. of 2748 shares of Cingulate at 4.76 subject to Rule 16b-3
at MacroaxisInsider 
Google News at Macroaxis
10th of January 2025
Roth MKM Initiates Coverage of Cingulate with Buy Recommendation - Nasdaq
at news.google.com 
Macroaxis News
31st of December 2024
Acquisition by Brams Matthew of 1000 shares of Cingulate at 4.93 subject to Rule 16b-3
at MacroaxisInsider 
Gurufocus Stories at Macroaxis
23rd of December 2024
Acquisition by Van Horn Louis G of 50000 shares of Cingulate at 1.79 subject to Rule 16b-3
at gurufocus.com 

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Cingulate in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Cingulate's short interest history, or implied volatility extrapolated from Cingulate options trading.
When determining whether Cingulate is a strong investment it is important to analyze Cingulate's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Cingulate's future performance. For an informed investment choice regarding Cingulate Stock, refer to the following important reports:
Check out Cingulate Backtesting and Cingulate Hype Analysis.
For more detail on how to invest in Cingulate Stock please use our How to Invest in Cingulate guide.
You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cingulate. If investors know Cingulate will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cingulate listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(43.22)
Return On Assets
(1.04)
Return On Equity
(2.74)
The market value of Cingulate is measured differently than its book value, which is the value of Cingulate that is recorded on the company's balance sheet. Investors also form their own opinion of Cingulate's value that differs from its market value or its book value, called intrinsic value, which is Cingulate's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cingulate's market value can be influenced by many factors that don't directly affect Cingulate's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cingulate's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cingulate is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cingulate's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.